Federica Galvagno

5PUBLICATIONS
48CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Sep 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Nov 02, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

Federica Galvagno, Valeria Leuci, Annamaria Massa

|Sep 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.

Ramona Rotolo, Valeria Leuci, Chiara Donini

|Sep 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.

Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio

Pageof 1

Frequent Collaborators

5 joint publications

Dario Sangiolo

4 joint publications

Elisa Vigna

4 joint publications

Chiara Donini

4 joint publications

Valeria Leuci